Nightingale Cardiology Research

Nightingale Cardiology Research Nightingale Research is one of Australia’s largest private cardiovascular clinical trial research organizations.

We provide access for patients to participate at the cutting edge and help develop medical technologies.

Nightingale Cardiology Research is now recruiting for the Surmount trial.Background:Cardiovascular outcome study compari...
26/02/2023

Nightingale Cardiology Research is now recruiting for the Surmount trial.
Background:
Cardiovascular outcome study comparing tirzepatide versus placebo in patients without diabetes, with obesity and increased cardiovascular risk.

If you have increased cardiovascular risk or established cardiovascular disease and are obese or overweight but do not have diabetes please contact us for more information at

research@nightingalecardiology.com

Nightingale Cardiology Research is now recruiting for a resistant hypertension study.BACKGROUND:High blood pressure that...
26/02/2023

Nightingale Cardiology Research is now recruiting for a resistant hypertension study.
BACKGROUND:
High blood pressure that is resistant to treatment is called resistant hypertension.

This study uses a Monoclonal Antibody injection IgG1 v placebo. This is a Phase II trial (to examine the effect of dose on blood pressure in people with with top blood pressure consistently greater than 145 mmHg already treated with three antihypertensive drugs of different classes.

These classes are specifically

-an ACEI/ARB,
-a long-acting dihydropyridine CCB, and
-a thiazide or thiazide-like diuretic

If you have resistant high blood pressure and are on multiple medications please contact us for more information at research@nightingalecardiology.com

Nightingale Research is now recruiting for the OCEANS Trial.BACKGROUND:Lipoprotein(a) is a new biomarker for cardiovascu...
26/02/2023

Nightingale Research is now recruiting for the OCEANS Trial.

BACKGROUND:
Lipoprotein(a) is a new biomarker for cardiovascular (CV) risk responsible for a large component of the cardiovascular risk in the population.

The Oceans trial is a registry study that assesses the prevalence (or presence in the community) of raised lipoprotein(a) in the blood, in patients with heart attack or coronary stent. A once-off blood test to detect Lipoprotein (a) is offered free.

If you have had heart attack or coronary stent please contact us for more information at research@nightingalecardiology.com

Address

Adelaide, SA
5000

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+61874444219

Website

Alerts

Be the first to know and let us send you an email when Nightingale Cardiology Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Nightingale Cardiology Research:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category